Experimental Weight-Loss Drug Slashed Fat in Livers of Obese People
WEDNESDAY, Nov. 15, 2023 (HealthDay News) — Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new research shows. A wider study, published in June, found that retatrutide helped obese people lose about a quarter of theirContinue Reading